Benchmarking the Cost per Person of Mass Treatment for Selected Neglected Tropical Diseases: An Approach Based on Literature Review and Meta-regression with Web-Based Software Application

PLoS Neglected Tropical Diseases

Volumn 10, Issue 12, 2016, Pages

  Fitzpatrick, Christopher ^a   Fleming, Fiona M ^b   Madin Warburton, Matthew ^a,c   Schneider, Timm ^d   Meheus, Filip ^e,f   Asiedu, Kingsley ^a   Solomon, Anthony W ^a   Montresor, Antonio ^a   Biswas, Gautam ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLCARBAMAZINE; ANTHELMINTIC AGENT;

ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ELIMINATION; DISEASE ERADICATION; HEALTH CARE COST; HELMINTHIASIS; HUMAN; LYMPHATIC FILARIASIS; NEGLECTED DISEASE; ONCHOCERCIASIS; POPULATION DENSITY; PUBLIC HEALTH SERVICE; SCHISTOSOMIASIS; SOCIOECONOMICS; TRACHOMA; TROPICAL DISEASE; WORLD HEALTH ORGANIZATION; YAWS; BENCHMARKING; ECONOMICS; ELEPHANTIASIS, FILARIAL; INTERNET; NEGLECTED DISEASES; PUBLIC HEALTH; SOFTWARE; TROPIC CLIMATE;

ANTHELMINTICS; BENCHMARKING; ELEPHANTIASIS, FILARIAL; HEALTH CARE COSTS; HEALTH EXPENDITURES; HELMINTHIASIS; HUMANS; INTERNET; NEGLECTED DISEASES; ONCHOCERCIASIS; PUBLIC HEALTH; PUBLIC HEALTH PRACTICE; SCHISTOSOMIASIS; SOFTWARE; TROPICAL CLIMATE;

EID: 85008684128     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0005037     Document Type: Article

References (25)

1. WHO | Investing to overcome the global impact of neglected tropical diseases [Internet]. [cited 19 Jun 2015]. Available: http://www.who.int/neglected_diseases/9789241564861/en/
2. WHO | Health service delivery costs [Internet]. [cited 19 Jun 2015]. Available: http://www.who.int/choice/cost-effectiveness/inputs/health_service/en/
3. McFarland D, Menzies N, Njoumemi Z, Onwujekwe O. Study of cost per treatment with ivermectin using the CDTI strategy. African Programme for Onchocerciasis Control (APOC); 2005.
4. IMF. World Economic Outlook Database April 2015 [Internet]. [cited 22 Jun 2015]. Available: https://www.imf.org/external/pubs/ft/weo/2015/01/weodata/index.aspx
5. PCT databank. In: WHO [Internet]. [cited 20 Oct 2015]. Available: http://www.who.int/neglected_diseases/preventive_chemotherapy/databank/en/
6. R Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2012. Available: http://www.R-project.org/
7. GDP per capita (constant 2005 US$) | Data | Table [Internet]. [cited 8 Apr 2015]. Available: http://data.worldbank.org/indicator/NY.GDP.PCAP.KD
8. Krishnamoorthy K, Ramu K, Srividya A, Appavoo NC, Saxena NB, Lal S, et al. Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis. Indian J Med Res. 2000;111: 81–89. 10937383
9. Frick KD, Lietman TM, Holm SO, Jha HC, Chaudhary JS, Bhatta RC, Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. Bull World Health Organ. 2001;79: 201–207. 11285663
10. Montresor A, Zin TT, Padmasiri E, Allen H, Savioli L, Soil-transmitted helminthiasis in Myanmar and approximate costs for countrywide control. Trop Med Int Health TM IH. 2004;9: 1012–1015. doi: 10.1111/j.1365-3156.2004.01297.x15361115
11. Fitzpatrick C, Asiedu K, Jannin J, Where the Road Ends, Yaws Begins? The Cost-effectiveness of Eradication versus More Roads. PLoS Negl Trop Dis. 2014;8: e3165. doi: 10.1371/journal.pntd.000316525255131
12. Conteh L, Patouillard E, Kweku M, Legood R, Greenwood B, Chandramohan D, Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children. PloS One. 2010;5: e12223. doi: 10.1371/journal.pone.001222320808923
13. Fiedler JL, Sanghvi TG, Saunders MK, A review of the micronutrient intervention cost literature: program design and policy lessons. Int J Health Plann Manage. 2008;23: 373–397. doi: 10.1002/hpm.92818438981
14. Boselli G, Yajima A, Aratchige PE, Feldon KE, Xeuatvongsa A, Phounphenghak K, et al. Integration of deworming into an existing immunisation and vitamin A supplementation campaign is a highly effective approach to maximise health benefits with minimal cost in Lao PDR. Int Health. 2011;3: 240–245. doi: 10.1016/j.inhe.2011.08.00224038496
15. Amarillo M, Belizario VJ, Panelo C, Sison S, de Leon W, Ramirez B, et al. Cost of mass drug administration for filariasis elimination in the province of Sorsogon, Philippines. Acta Med Philipp. 2009;43: 23–28.
16. Goldman AS, Guisinger VH, Aikins M, Amarillo MLE, Belizario VY, Garshong B, et al. National mass drug administration costs for lymphatic filariasis elimination. PLoS Negl Trop Dis. 2007;1: e67. doi: 10.1371/journal.pntd.000006717989784
17. Goldman AS, Brady MA, Direny A, Desir L, Oscard R, Vely J-F, et al. Costs of integrated mass drug administration for neglected tropical diseases in Haiti. Am J Trop Med Hyg. 2011;85: 826–833. doi: 10.4269/ajtmh.2011.10-063522049035
18. Hodges MH, Smith SJ, Fussum D, Koroma JB, Conteh A, Sonnie M, et al. High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone. Parasit Vectors. 2010;3: 120. doi: 10.1186/1756-3305-3-12021162751
19. McLaughlin SI, Radday J, Michel MC, Addiss DG, Beach MJ, Lammie PJ, et al. Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000. Am J Trop Med Hyg. 2003;68: 568–573. 12812348
20. Ramzy RMR, Goldman AS, Kamal HA, Defining the cost of the Egyptian lymphatic filariasis elimination programme. Filaria J. 2005;4: 7. doi: 10.1186/1475-2883-4-716076397
21. Turner HC, Osei-Atweneboana MY, Walker M, Tettevi EJ, Churcher TS, Asiedu O, et al. The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study. PLoS Negl Trop Dis. 2013;7: e2452. doi: 10.1371/journal.pntd.000245224069497
22. Kim YE, Sicuri E, Tediosi F, Turner HC, Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa. PLoS Negl Trop Dis. 2015;9: e0004056. doi: 10.1371/journal.pntd.000405626360917
23. Klepac P, Funk S, Hollingsworth TD, Metcalf CJE, Hampson K, Six challenges in the eradication of infectious diseases. Epidemics. 2015;10: 97–101. doi: 10.1016/j.epidem.2014.12.00125843393
24. Klepac P, Metcalf CJE, McLean AR, Hampson K, Towards the endgame and beyond: complexities and challenges for the elimination of infectious diseases. Philos Trans R Soc Lond B Biol Sci. 2013;368: 20120137. doi: 10.1098/rstb.2012.013723798686
25. Harding-Esch E, Jofre-Bonet M, Dhanjal JK, Burr S, Edwards T, Holland M, et al. Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study. PLoS Negl Trop Dis. 2015;9: e0003670. doi: 10.1371/journal.pntd.000367025901349